Xenical Obesity Agent Targeted By Public Citizen, Citing Pre-cancer Ties
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Public Citizen is calling for the withdrawal of Roche's prescription obesity drug Xenical (orlistat) just days after FDA issued an "approvable" letter to GlaxoSmithKline for an over-the-counter version of the drug